BridgeBio Pharma Inc (BBIO) USD0.001
0.52%- This stock can be held in a
Stocks and Shares ISASell:$44.85
Buy:$44.86
Change:
$0.26
(0.58%)
$0.26
(0.58%)Market closed | Prices delayed by at least 15 minutes
Sell:$44.85
Buy:$44.86
Change:$0.26
(0.58%)
$0.26
(0.58%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 June 2025 | Francis Patrick (Frank) McCormickIndependent Director | Sell Regular sell transaction (market) | 100,000 | $44.23 | $4,422,800.00 | 879,979 |
| 10 June 2025 | Hannah A ValantineIndependent Director | Sell Option/Award related | 4,292 | $40.00 | $171,680.00 | 1,764 |
| 20 May 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 75,000 | $33.40 | $2,504,977.50 | 4,798,447 |
| 19 May 2025 | Neil KumarCEO | Sell Option/Award related | 25,756 | $33.32 | $858,264.61 | 217,804 |
| 19 May 2025 | Neil KumarCEO | Sell Option/Award related | 400 | $33.75 | $13,499.00 | 217,404 |
| 16 May 2025 | Thomas TrimarchiPresident/COO | Sell Tax related | 21,317 | $33.84 | $721,367.28 | 501,988 |
| 16 May 2025 | Neil KumarCEO | Sell Tax related | 32,854 | $33.84 | $1,111,779.36 | 243,560 |
| 16 May 2025 | Maricel M ApuliChief Accounting Officer | Sell Tax related | 4,780 | $33.84 | $161,755.20 | 142,859 |
| 12 May 2025 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 6,000,000 | $34.20 | $205,200,000.00 | 13,260,971 |
| 2 May 2025 | Maricel M ApuliChief Accounting Officer | Sell Regular sell transaction (market) | 1,026 | $38.51 | $39,509.11 | 147,639 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 May 2025 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 6,000,000 | $34.20 | $205,200,000.00 | 13,260,971 |
| 5 March 2025 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 6,000,000 | $32.96 | $197,760,000.00 | 19,260,971 |
| 13 September 2024 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 5,800,000 | $25.75 | $149,350,000.00 | 25,260,971 |
| 31 January 2025 | VIKING GLOBAL INVESTORS LPHedge Fund | Sell Regular sell transaction (market) | 3,065,616 | $34.90 | $106,989,998.40 | 22,055,375 |
| 28 January 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 326,932 | $36.29 | $11,863,381.48 | 5,371,515 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.